The first 2 authors contributed equally to this study.
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma†
Comparison of results in human immunodeficiency virus-infected and noninfected patients
Article first published online: 5 MAY 2008
Copyright © 2008 American Cancer Society
Volume 113, Issue 1, pages 117–125, 1 July 2008
How to Cite
Oriol, A., Ribera, J.-M., Bergua, J., Giménez Mesa, E., Grande, C., Esteve, J., Brunet, S., Moreno, M.-J., Escoda, L., Hernandez-Rivas, J.-M. and Hoelzer, D. (2008), High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma. Cancer, 113: 117–125. doi: 10.1002/cncr.23522
Results previously presented at the 49th ASH Annual Meeting, Atlanta, Georgia, December 8-11, 2007.
- Issue published online: 20 JUN 2008
- Article first published online: 5 MAY 2008
- Manuscript Accepted: 18 FEB 2008
- Manuscript Revised: 14 FEB 2008
- Manuscript Received: 27 DEC 2007
- FIS. Grant Number: 051490
- Deutsche Jose Carreras Leukamie-Stiftung e.V.. Grant Number: DJCLS H 06/03
- RETICS, Instituto de Salud Carlos III. Grant Number: RD06/0020/1056
- 5Intensive chemotherapy with cyclophosphamide, doxorubicine, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003; 98: 1196–1205., , , et al.
- 6Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer. 2002; 94: 1492–1499., , , et al.
- 11High survival rate in adults Burkitt's lymphoma/leukemia and diffuse large B-cell lymphoma with mediastinal involvement. Blood. 2007; 110: 159a., , , et al.
- 14MittelmanF (ed). ISCN: An International System for Human Cytogenetic Nomenclature. Basel: Karger; 1995.
- 18Regression models and life tables. J Roy Stat Soc Ser B. 1972; 34: 187–220..
- 23Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma. Results of a phase II trial. Br J Haematol. 2008; 140: 411–419., , , et al.
- 25Long-term outcome after hyper-CVAD and rituximab chemoimmunotherapy for Burkitt or Burkitt-like leukemia/lymphoma and mature B-cell acute lymphocytic leukemia. Blood. 2007; 118: 831a., , , et al.